Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Condorelli, M.
Right arrow Articles by Brevetti, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Condorelli, M.
Right arrow Articles by Brevetti, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Intermittent claudication: an historical perspective

M. Condorelli* and G. Brevetti

Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University di Napoli Federico II, Naples, Italy

* Correspondence: M. Condorelli MD, Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University di Napoli Federico II, via Sergio Pansini 5, I-80131 Naples, Italy.

Abstract

The present review addresses the history of intermittent claudication in terms of pathogenetic and therapeutic approach. The reduced blood supply to the affected limb was initially explained by ‘vasospasm theory’, and vasodilators were the first drugs to be used. However, the demonstration that they induce the blood steal phenomenon led to the demise of vasodilating therapy. The 1970s marked the shift in interest from ‘vessel’ to ‘blood’, and drugs that improve blood rheology were introduced. In the 1990s, research focused on the metabolic regulation of the ischaemic muscle, and the ‘metabolic therapy’ has emerged as a new approach with which to improve walking capacity in claudicant patients.

Key Words: Intermittent claudication • pathophysiology of intermittent claudication • peripheral artery disease • therapy of intermittent claudication

References

  1. Bouley JF. Claudication intermittente des membres postérieurs délcrminée par l'oblitération des artècres fémorales. Rec Med Vet. 1831;8:517
  2. Brodie BC. Lectures Illustratives of Various Subjects in Pathology and Surgery. London: A. Spottiswoode; 1846. (Cited by Lewis et al.[10])
  3. Charcot JMC. Sur la claudication intermittente observe dans un cas d'oblitération complete de Tune des artéeres iliaques primitives. CR Soc Biol (Paris). 1858;5:225 (Cited by Lindquist[7])
  4. Erb WÜ. Das intermittierende hinken and andere nervöse Störungen in folge I. Von Gefässerkrankungen Z Nervenk. 1898;13:1
  5. Comroe JH. Paroxysmal angiospasm dolorosa. Ann Clin Med. 1922;1:313–316
  6. Leary WV, Allen EV. Intermittent claudication as a result of arterial spasm induced by walking. Am Heart J. 1941;22:719–724[CrossRef][Web of Science]
  7. Lindquist T. Intermittent claudication and vascular spasm. I. Is vascular spasm a contributing cause of intermittent claudication in patients with structural disease of the arteries? Acta Med Scand. 1945;121:32–44
  8. Ejrup B. Tonoscillography after exercise. Acta Med Scand Suppl. 1948;211:1–7
  9. Thulesius O. Haemodynamic studies on experimental obstruction of the femoral artery in the cat. Acta Physiol Scand Suppl. 1962;199:1–9
  10. Lewis T, Pichering G, Rotschild P. Observations upon muscular pain in intermittent claudication. Heart. 1931;15:359–366[Web of Science]
  11. De Bakey ME, Burch G, Thorpe R, Ochsner A. The borrowinglending haemodynamic phenomenon (hemometakinesia) and its therapeutic application in peripheral vascular disturbances. Ann Surg. 1947;126:880–887
  12. Wezler K. Die Function der Peripheren Strombahngebiete. Regensburg. JB Ärztl Forbild. 1954;II/X:462
  13. Ashton H. Critical closing pressure in the human peripheral vascular beds. Clin Sci. 1962;22:79–86[Web of Science][Medline]
  14. Skinner JS, Strandness DE. Exercise and intermittent claudication. 1. Effects of repetition, and intensity of exercise. Circulation. 1967;36:15–22[Abstract/Free Full Text]
  15. Winsor T, Hyman C, Payne JH. Exercise and limb circulation in health and disease. Arch Surg (Chicago). 1959;78:184–190
  16. Allwood MJ. Redistribution of blood flow limbs with obstruction of a main artery. Clin Sci. 1962;22:279–288[Web of Science][Medline]
  17. Hansteen V, Lorentsen E. Vasodilator drugs in the treatment of peripheral arterial insufficiency. Acta Med Scand Suppl. 1974;556:3–62[Medline]
  18. Gillespie JA. An evaluation of vasodilation drugs in occlusive vascular disease by measurement. Angiology. 1966;17:280–285
  19. Coffman JD, Mannick JA. Failure of vasodilator drugs in arteriosclerosis obliterans. Ann Intern Med. 1972;76:35–39
  20. Chiariello M, Ribeiro LGT, Davis MA, et al. ‘Reverse coronary steal’ induced by coronary vasoconstriction following coronary occlusion in dogs. Circulation. 1977;56:809–815[Abstract/Free Full Text]
  21. Brevetti G, Rengo F, Chiariello M, et al. Reduction of blood flow following ischemia in arteriopathic patients: reversion of the phenomenon induced by propranolol. Angiology. 1977;28:687–694
  22. Brevetti G, Chiariello M, Rengo F, et al. Protective effects of the propranolol on the exercise induced reduction of blood flow in arteriopathic patients. Angiology. 1979;30:696–702
  23. Brevetti G, Chiariello M, Ferulano GP, et al. Propranolol-induced riverse vascular steal in arteriopathic patients. Angiology. 1982;33:78–89
  24. Dormandy JA, Hoare E, Colley J, et al. Clinical, haemodynamic, theological, and biochemical findings in 126 patients with intermittent claudication. BMJ. 1973;4:576–581
  25. Dormandy JA, Hoare E, Khattab AH, et al. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. BMJ. 1973;4:581–583
  26. Reid HL, Dormandy JA, Barnes AJ, et al. Impaired red cell deformability in peripheral vascular disease. Lancet. 1976;1:666–668[Web of Science][Medline]
  27. Ciuffetti G, Mercari M, Bombardini M, et al. Leukocyte behaviour in controlled ischaemia of the calves. J Clin Pathol. 1989;42:1083–1087[Abstract/Free Full Text]
  28. Neumann FJ, Wass W, Diehm C, et al. Activation and decreased deformability of neutrophils after intermittent claudication. Circulation. 1990;82:922–929[Abstract/Free Full Text]
  29. Hess H, Franke I, Jauch M. Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases. [in German]Fortschr Med. 1973;91:743–748[Medline]
  30. Heidrich H, Schlichting K, Ott M. Changes in blood viscosity due to pentoxifyline. IRCS Med Sc. 1976;4:368–372
  31. Brevetti G, Abate S, La vecchia G, et al. La pentossifillina net trattamento defle arteriopatia obliteranti al secondo stadio. Progr Med. 1979;35:363–368
  32. Ehrly AM. The effects of pentoxifyline on the deformability of erythrocytes and or the muscular oxygen pressure in patients with chronic arterial disease. J Med. 1979;10:331–338[Web of Science][Medline]
  33. Schmalzer EA, Chien S. Filterability of subpopulation of leukocytes: effect of pentoxifyline. Blood. 1984;64:542–546[Abstract/Free Full Text]
  34. Cameron HA, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of the published clinical trials 1965–1985. Br J Clin Pharmacol. 1988;26:569–576[Web of Science][Medline]
  35. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med. 1997;113:135–146
  36. Hiatt WR, Nawaz D, Regensteiner JG, Hossack KF. The evaluation of exercise performance in patients with peripheral vascular disease. J Cardiopulm Rehab. 1988;12:525–532
  37. Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP. Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol. 1992;73:346–353[Abstract/Free Full Text]
  38. Regensteiner JC, Wolfel EE, Brass EP, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation. 1993;87:413–421[Abstract/Free Full Text]
  39. Lundgren F, Dahllof AG, Schersten T, Bylund-Fellenius AC. Muscle enzyme adaptation, effect of different treatments and consequences on walking performance. Clin Sci. 1988;77:485–493
  40. Kemp GJ, Hands LJ, Ramaswani G, et al. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy. Clin Sci. 1995;89:581–590[Medline]
  41. Pipinos II, Shepard AD, Anagnostopoulos PV, Katsamouris A, Boska MD. Phosphoros 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicatiog skeletal muscle. J Vasc Surg. 2000;31:944–952[CrossRef][Web of Science][Medline]
  42. Cerretelli P, Marconi C. L-carnitine supplementation in humans the effects on physical performance. Int J Sports Med. 1990;11:1–14[Web of Science][Medline]
  43. Hiatt WR, Regensteiner JG, Wolfe] EE, Ruff L, Brass EE. Carnitine and acylcarnitine metabolism during exercise in humans: dependence on skeletal muscle metabolic state. J Clin Invest. 1989;84:1167–1173
  44. Hiatt WR, Nawaz D, Brass EP. Carnitine metabolism during exercise in patients with peripheral vascular disease. J Appl Physiol. 1987;62:2383–2387[Abstract/Free Full Text]
  45. Brevetti G, Angelini C, Rosa M, et al. Muscle carnitine deficiency in patients with severe peripheral vascular disease. Circulation. 1991;84:1490–1495[Abstract/Free Full Text]
  46. Brevetti G, Di Lisa F, Perna S, et al. Carnitine related alterations in patients with intermittent claudication. Indication for carnitine therapy. Circulation. 1996;93:1685–1689[Abstract/Free Full Text]
  47. Brevetti G, Chiariello M, Ferulano G, et al. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double blind, cross-over study. Circulation. 1988;77:767–773[Abstract/Free Full Text]
  48. Brevetti G, Fania M, De Amicis T, et al. Changes in skeletal muscle histology and metabolism in patients undergoing exercise deconditioning: effect of propionyl-L-carnitine. Muscle Nerve. 1997;20:1515–1519[CrossRef][Web of Science][Medline]
  49. Tassani V, Cattapan F, Magnanimi L, Peschechera A. Anaplerotic effect of propionyl-carnitine in rat heart mitochondrial. Biochem Biophys Res Commun. 1994;199:949–953[CrossRef][Web of Science][Medline]
  50. Brevetti G, Perna S, Sabbà C, et al. Superiority of L-propionyl carnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous doubleblind, cross-over study. Eur Heart J. 1992;133:251–255
  51. Brevetti G, Perna S, Sabbà C, et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo, controlled, dose titration, Multicenter study. J Am Coll Cardiol. 1995;26:1411–1416[Abstract]
  52. Brevetti G, Perna S, Sabbà C, et al. Effect of propionyl-L-carnitine on quality of life in intermittent claudication. Am J Cardiol. 1997;79:777–780[CrossRef][Web of Science][Medline]
  53. Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol. 1999;34:1618–1624[Abstract/Free Full Text]
  54. Foley WT. Treatment of gangrene of the feet and legs by walking. Circulation. 1957;15:689–692[Web of Science][Medline]
  55. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1996;274:975–980
  56. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602–609[Abstract/Free Full Text]
  57. Hickey NC, Gosling P, Baar S, Shearman CP, Simms MH. Effect of exercise on the systemic inflammatory response to intermittent claudication. Br J Surg. 1990;77:1121–1124[Web of Science][Medline]
  58. Hickman P, Harrison DK, Hill A, et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol. 1994;361:565–570[Medline]
  59. Khaira HS, Nash GB, Bahra PS, et al. Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury. Eur J Vasc Endovasc Surg. 1995;10:31–35[CrossRef][Web of Science][Medline]
  60. Kirk G, Hickman P, McLaren M, et al. Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg. 1999;18:434–438[CrossRef][Web of Science][Medline]
  61. Mangiafico RA, Malatino LS, Spada RS, et al. Treadmill exerciseinduced release of endothelin-1 patients with peripheral arterial occlusive disease at Fontaine stage IIb. Int Angiol. 2000;19:14–17[Web of Science][Medline]
  62. Bode-Boger SM, Boger RH, Alfke H, et al. L-Arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation. 1996;93:85–90[Abstract/Free Full Text]
  63. Boger RH, Bode-Boger SM, Thiele W, et al. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol. 1999;32:1336–1344
  64. Hickey NC, Shearman CP, Gosling P, Simms MA. Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria. Eur J Vasc Surg. 1990;4:601–606
  65. Iwata H, Matsushita M, Nishikimi N, Sakwai T, Nimura Y. Intestinal permeability is increased in patients with intermittent claudication. J Vasc Surg. 2000;31:1003–1007[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Condorelli, M.
Right arrow Articles by Brevetti, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Condorelli, M.
Right arrow Articles by Brevetti, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?